Background--The physiological function of ADTRP (androgen-dependent tissue factor pathway inhibitor regulating protein) is unknown. We previously identified ADTRP as coregulating with and supporting the anticoagulant activity of tissue factor pathway inhibitor in endothelial cells in vitro. Here, we studied the role of ADTRP in vivo, specifically related to vascular development, stability, and function.
A DTRP (Androgen-dependent tissue factor pathway inhibitor [TFPI]-regulating protein) was first described in our laboratory as a novel and uncharacterized protein encoded by C6ORF105.
1 Based on sequence homology, ADTRP belongs to the androgen-inducible gene family, of which androgeninducible gene 1 was cloned from human dermal papilla. 2 In endothelial cells (ECs) in vitro, ADTRP regulates expression and activity of TFPI, the major inhibitor of the tissue factordependent pathway of coagulation, both in normal conditions and in response to androgen, 1 the latter involving transcriptional activation through half-site androgen-response elements in the ADTRP promoter. 1, 3 Genome-wide association studies revealed that single-nucleotide polymorphisms in ADTRP associate with deep vein thrombosis/venous thromboembolism, 4 myocardial infarction, 5 and coronary artery disease, possibly through regulation of melanoma inhibitory activity protein 3 (MIA3)/transport and Golgi organization protein 1 (TANGO1), collagen VII, and apolipoprotein B (ApoB). 6, 7 A novel function was recently discovered for ADTRP and androgen-inducible gene 1, namely that they could hydrolyze bioactive fatty acid esters of hydroxy-fatty acids in vitro 8 ; however, the in vivo significance of this finding is elusive. Because the physiological function of ADTRP was still unknown, we addressed in the present study the role of ADTRP in vascular development and function using zebrafish and mouse animal models.
L-Wnt3a cells (ATCC CRLÀ2647) and L-Cells (ATCC CRL-2648) to prepare Wnt-conditioned and control media as per ATCC (Manassas, VA) instructions.
We isolated mouse dermal fibroblasts from newborn pups (P 0 ) cephalic skin explants 20 separately from 4 Adtrp À/À pups
Clinical Perspective
What Is New?
• We describe the role of ADTRP (androgen-dependent tissue factor pathway inhibitor regulating protein) in vivo using mouse and zebrafish models of Adtrp genetic inhibition.
• We show that ADTRP deficiency leads to leaky vessels, edema, and hemorrhage involving defective junctions, matrix degradation, and local inflammation, possibly because of ectopic/increased Wnt signaling, accumulation of mast cells, and increased MMP-9 expression.
What Are the Clinical Implications?
• Given that gene association studies suggested that ADTRP associates with deep vein thrombosis/venous thromboembolism, myocardial infarction, and coronary artery disease in humans, ADTRP deficiency affecting vascular homeostasis/ stability may negatively impact cardiovascular diseases through pathological disruption of the vascular wall, matrix degradation, and increased inflammation.
and 2 wild-type (WT) pups, and used them for up to 5 passages.
Animal Studies
All animal procedures followed were approved by the institutional animal care and use committee.
Generation of the mouse model of Adtrp global deletion
The conditional null allele for the Adtrp gene was generated by Dr Dale Cowley (University of North Carolina), using the bacterial artificial chromosome gene targeting strategy, 21 to simultaneously introduce LoxP sites flanking both exons 2 and 5 of 9530008L14RIK gene (mouse Adtrp). We needed this approach because exons 2 to 5 of the Adtrp gene share inframe splice junctions, so that removal of only 1 of exons 2, 3, or 4 would not produce a frameshift event. Also, the removed exons should encode key protein functions so their excision would inactivate any residual protein produced if the mRNA is not degraded; but, in the case of Adtrp, we did not know which exons were critical for its function. According to the sequence analysis, removal of exon 5 triggers nonsense mRNA decay, and the additional removal of exon 2 ensures that any residual mRNA would not produce a functional polypeptide. The bacterial artificial chromosome targeting vector was designed to introduce: (1) LoxP1 site in intron 1; (2) LoxP2 site and FRT-flanked Neo-resistance cassette in intron 2; (3) LoxP3 site in intron 4; and (4) LoxP4 site and FRTflanked Hyg-cassette in intron 5. After validation, the bacterial artificial chromosome was introduced into C57BL/6 embryonic stem cells, which were injected into albino blastocysts and the chimeras were mated to albino-C57BL/6 females. Black offspring positive for the mutant allele were crossed with ROSA26-Flpe + mice to remove Hyg and Neo cassettes. In this process, Flpe recombinase also deleted the entire region between exons 3 and 5, and we selected Adtrp Harbor, ME). The age of the mice was P 0 (newborn) for the majority of the studies. The use of 2-to 3-month-old young adults for a small number of assays is indicated in the appropriate sections.
Zebrafish husbandry and drug treatments
WT and transgenic Tg(fli1:EGFP)y1 zebrafish and their embryos were grown and maintained under standard conditions. 22, 23 Embryonic pigmentation was inhibited with 0.2 mmol/L of N-phenylthiourea (Sigma-Aldrich) and chorions removed with 1 mg/mL of pronase (Calbiochem, San Diego, CA). For blocking Mmp-9 activity, dechorionated embryos at 48 hours postfertilization (hpf) were incubated with 100 lmol/L of GM6001 [24] [25] [26] [27] of the adtrp premature mRNA were used to knock down adtrp expression. Controls included scrambled (5ʹ-CTCTT ACCTCAGTTACAATTTATA-3ʹ) and p53 (5ʹ GCGCCATTGCTTTG CAAGAATTG-3ʹ) MOs. 31 Capped and polyadenylated human ADTRP mRNA was synthesized from pCMV6-Entry/ADTRP-FLAG (OriGene) using the mMESSAGE mMACHINE kit (Ambion, Austin, TX). MOs were microinjected into 1-to 4-cell-stage embryos using 1 pmol/embryo for adtrp MOs (e2i2 or e3i3)AE1.5 pmol/embryo of p53 MOs or 350 pg/ embryo of ADTRP mRNA. All microinjections were performed as described.
32,33
Gene Expression, Transcriptional Reporter Assay, and RNA Silencing protein 6 (LRP6)DN-pCS2-VSVG, were assayed for luciferase activity after 48 hours.
For silencing experiments, ADTRP-siRNA or negative control (OriGene) were transfected in EA.hy926 cells using Lipofectamine 2000 (Thermo Fisher Scientific).
Quantitative Real-Time PCR Total RNA isolated from zebrafish embryos, cultured cells, and mouse tissues using Trizol (Invitrogen) was purified and transcribed into cDNA as described.
1 qPCR was performed using predesigned primers (Prime-Time, Integrated DNA Technologies Inc, Coralville, IA) and RT 2 SYBR Green master mix (Qiagen) in a CFX96 Real Time System (Bio-Rad). Experiments were repeated 3 times using at least 10 zebrafish embryos/condition and mouse samples from 6 individual pups/genotype as biological replicates. For cells in culture, the experiments were repeated at least 2 (usually 3) times using 3 replicate culture wells per condition. All qPCRs were run in duplicate on each cDNA.
In Situ Hybridization
Whole-mount in situ hybridization (ISH) was performed using zebrafish adtrp and matrix metalloproteinase 9 (mmp9) digoxigenin-labeled riboprobes essentially as described. 35, 36 mmp9 riboprobe was a kind gift from Dr David Jones (Oklahoma Medical Research Foundation). ISH for adult (2 months old) mouse aorta and lung sections was performed using mouse Adtrp riboprobe essentially as described. 37 For imaging, we used a Nikon SMZ18 stereomicroscope (Nikon Corp., Tokyo, Japan) with DSFI2 camera and NIS-Elements (version 4.2) software or the Nikon Eclipse E800M with an OMAX A35140u camera and OMAX ToupView (3.7.2270) software (ToupTek Photonics, Hangzhou City, China).
Immunofluorescence, Image Acquisition, and Image Analysis
Immunofluorescence staining was done as whole mount on pieces of organs from newborn mouse pups, as well as on cryosections of zebrafish caudal vein plexus (CVP), and cell culture as described. 1, 38, 39 We used a modification of the iDISCO procedure 40 for whole-mount sample collection, pretreatment without methanol, and immunolabeling without tissue clearing. Samples were mounted with Vectashield (Vector Laboratories, Inc, Burlingame, CA) on homemade slide chambers. Samples were analyzed based on endogenous enhanced green fluorescent protein or immunofluorescence using the Nikon C1 confocal system on a Nikon TE2000U microscope with EZ-C1 (Version 3.6; Nikon) software 1 or a Nikon Eclipse Ti-E inverted microscope and an Andor Zyla 4.2
Plus sCMOS camera using NIS-Elements AR4.5 (Nikon) software. The confocal system objectives were all Nikon Infinity-Corrected: dry PlanFluor 20x/NA0.75 and 20x/NA0.5, and oil-immersion PlanFluor 40x/NA1.3, PlanApo 60x/NA1.4, and PlanFluor 100x/NA1.3. Image collection parameters (neutral density filters, pinhole, and detector gains) were kept constant during image acquisition to make reliable comparisons between specimens. Image acquisition was done sequentially for each fluorescence channel to avoid bleedthrough. Quantification of fluorescence intensity and image analysis were done as described. 19, 41 For whole-mount samples, 10 to 15 images (12-bit, 4095 gray levels/pixel) were collected for each experimental condition, and mean fluorescence intensity, expressed as arbitrary units, was measured for the whole image, or in 15 to 20 regions of interest per image (as specified in the figure legends). For cell cultures, mean fluorescence intensity was measured in the whole nucleus in a minimum of 20 cells per group, randomly chosen from at least 5 images for each experiment. For all conditions, mean fluorescence intensity was integrated using EZ-C1 software. All primary antibodies used were obtained from commercial sources and tested by us and other groups as described in previous publications. Omission of primary antibody or substitution with isotype-specific immunoglobulin Gs at the same concentration as the primary antibody were used as controls for nonspecific binding of the secondary antibody.
For zebrafish embryos, total percentage of defective intersegmental vessels (ISVs) was quantified by counting the number of vessels not reaching the dorsal longitudinal anastomotic vessel at 48 or 72 hpf. Percentage of CVP dilation was calculated as the ratio between CVP area and the total area of the tail posterior to the yolk sac.
Histological analysis was done on paraffin sections stained with phosphotungstic acid or hematoxylin and eosin. 41 Brightfield images were obtained with a Nikon SMZ800 stereomicroscope using Nikon HR Plan Apo 0.5x objective and OMAX camera and ToupView software (as above).
Transmission Electron Microscopy
Pieces of cephalic skin (191-mm) and tail rings from newborn pups and 72-hpf zebrafish embryos were fixed by immersion in Karnovsky's fixative and processed essentially as described. 42 Semithin (500 nm) and ultrathin sections In situ zymography was done essentially as described. 43 We used a quenched fluorescence MMP substrate, which, upon cleavage by MMPs, becomes dequenched and gives a fluorescent signal. Sections (10-lm) of unfixed 48-hpf zebrafish embryos embedded in OCT were taken on glass slides and washed with PBS. Quenched MMP fluorescence substrate QXL 570-KPLA-Nva-Dap(5-TAMRA)-AR-NH2 (AnaSpec) was used according to the manufacturer's instructions. After mixing with 0.1% low-melting agarose, the substrate was overlaid on tissue sections and slides were incubated at 37°C until a satisfactory fluorescence signal was achieved. Fluorescence microscopy images were taken by a confocal microscope as described above.
Western Blot
Protein lysates from 72-hpf zebrafish embryos, mouse P 0 cephalic skin, or cell cultures were subjected to SDS-PAGE and western blot as described. 
Ortho-Dianisidine Staining
Staining was done as described. 44 
Other Assays
Tail bleeding time and hemoglobin assay were performed as described. 45 TFPI antigen, measured by DuoSet ELISA (R&D Systems), and activity, measured by 2-stage chromogenic assay using human coagulation factors, 39, 46 were determined in plasma and lung lysates. 46 
Data Collection and Statistical Analysis
All results are reported as meanAESEM or meanAESD. Statistical analysis was performed with GraphPad Prism software (v7.0b RRID:SCR_002798; GraphPad Software Inc, La Jolla, CA). An unpaired t test was used to analyze 2 experimental conditions, whereas 1-way ANOVA followed by Bonferroni's multicomparison test were used when comparing more than 2 data sets. Differences were considered significant when P≤0.05. Analysis of cell and tissue microscopy specimens was done in a blinded manner. All experiments were repeated at least 3 times, with each assay typically run in triplicate.
Results

Knockdown of adtrp Causes Vascular Defects in Zebrafish Embryos
ISH revealed that adtrp is expressed in the developing vasculature ( Figure 1A through 1D ) in the anterior, medial, and posterior lateral plate mesoderm (arrows), where populations of angioblasts reside. Adtrp is expressed in both the dorsal aorta and cardinal vein ( Figure 1B and 1C, right-side panel) and increases during embryogenesis ( Figure 1F ). The role of adtrp in vascular development and function was investigated by knocking down adtrp1 (adtrp homologous gene located on chromosome 23; hereafter named "adtrp") in Tg(fli1: EGFP)y1 embryos using adtrp e2i2 or adtrp e3i3 MOs (Figure 2A ).
After preliminary testing of a range of MO concentrations, we chose 1 pmol of MO/embryo as the dose producing both an acceptable mortality rate (%25%) and a knockdown efficiency of %50% at 72 hpf, as assessed by qPCR, for both spliceblocking MOs versus control MO ( Figure 2B ). The 72-hpf whole embryos displayed no significant changes in expression of the adtrp2 homolog on chromosome 13 ( Figure 2C ), which indicates that adtrp1 deficiency is the sole cause of the phenotypic changes observed.
As illustrated by the intrinsic enhanced green fluorescent protein fluorescence of embryo blood vessels visualized by whole-mount confocal microscopy ( Figure 3A ), adtrp knockdown produced defective patterning of ISVs (white arrows and insets, Figure 3A ) and significantly reduced the vessels' development ( Figure 3B ; quantitative analysis of ISVs). Disorganization of the CVP network (dashed line areas; Figure 3A , 3D, and 3F) and plexus dilation/edema ( Figure 3C ; quantitative measurement of CVP area) also occurred. To assess the specificity of MO effects, the adtrp MO was coinjected with human ADTRP-FLAG mRNA. The human ADTRP protein expressed in the adtrp morphants, as demonstrated by western blot with anti-FLAG immunoglobulin G ( Figure 3A lowest panel) partially rescued the ISV and CVP defects ( Figure 3A through 3C). By transmission electron microscopy, the EC layer surrounding dilated CVP appears intact ( Figure 3D , panel c).
We also observed hemorrhage spots in the head and CVP region of adtrp morphants as shown by O-dianisidine staining ( Figure 3E ).
Similar ISV and CVP network defects also appeared for the adtrp e3i3 MOs ( Figure 3F ).
To preclude cell death as a cause for the observed phenotype, we coinjected p53+adtrp e2i2 MOs and observed nearly identical responses in both adtrp e2i2 and p53+adtrp e2i2 morphants, but not in embryos injected with p53 MOs alone ( Figure 3F ). Because penetrance of the vascular phenotype was >80% for all the combinations tested (Table 1) , even at %50% knockdown efficiency, we used adtrp e2i2 MOs, hereafter referred to as "adtrp" MOs, for all adtrp knockdown experiments.
Generation and Characterization of the Mouse Model of Adtrp Global Deletion
Adtrp expression in whole embryos of WT (C57BL/6) mice gradually increased during embryogenesis ( Figure 4A ). ISH in lung and aorta of 2-month-old WT mice showed strong expression of Adtrp in ECs ( Figure 4B ).
Adtrp global knockout mice were obtained as described in the Materials and Methods section and are illustrated in Figure 5A through 5C. Additional PCRs (data not shown) confirmed the removal of the Hyg and Neo cassettes and the lack of Flpe expression in the final mouse line selected for backcrossing. qPCR for Adtrp in various organs showed that Adtrp À/À mice had minimal mRNA expression, thus confirming the efficiency of gene deletion ( Figure 5D ). Thirty-five percent of Adtrp À/À pups are stillborn or expire neo-/perinatal ( Figure 5E and 5F). Given that the number of Adtrp À/À progenies from heterozygous pairs is significantly lower than Mendelian prediction ( Figure 5E ), substantial lethality likely occurred during late gestation. Pups who survive do grow into adulthood, and, although their reproduction rate is lower than WT littermates, there is no significant difference in litter sizes ( Figure 5F ).
Newborn Adtrp À/À Mice Show Defective Vasculature
Vascular defects, easily observed in newborn pups (P 0 ) through transparency in the cephalic skin ( Figure 6A ), as well as in the meningeal layers, thoracic wall, heart, eye, kidney, Flpe-Del/Flpe-Del , which was selected as the constitutive global knockout mouse, Adtrp À/À . B, Genomic DNA extracted from toe tips was subjected to PCR using primers pair #1, specific for LoxP1 site, to confirm the presence of lox allele. Homozygous Adtrp LoxP1/LoxP1 mice were further screened for the Flpe deletion by using primers pair #2, which amplifies a 511-bp product only if the recombination occurred between exons 3 to 5. C, Agarose gel showing an example of genotyping (grayscale-mode inverted image). D, mRNA expression of Adtrp assayed by qPCR in cephalic skin, lung, and heart of newborn (P 0 ) pups shows minimal expression in Adtrp Figure 6D ). We did not observe obvious changes in the morphology of the large vessels, such as the aorta. Severity of vascular defects correlated with the neo-/perinatal mortality.
We confirmed vessel leakiness in Adtrp À/À P 0 pups with the permeability tracer, Sulfo-NHS-Biotin (intracardiac infusion), 47 followed by whole-mount staining with streptavidin-Cy3 (cephalic skin; Figure 7A ) and semiquantitative analysis (Figure 7E ). Hemorrhage spots ( Figure 7A ) and extravascular fibrin deposition appeared in the skin ( Figure 7B ), as well as in brain, heart, kidney, and lung (data not shown). Adtrp À/À P 0 pups displayed lower levels of VEC ( Figure 7C and 7F) and claudin-5 ( Figure 7D ) than WT mice. qPCR, using RNA from skin, lung, and heart, showed %2-fold decreased expression of both Cdh5 (VEC) and Cldn5 (claudin-5) in Adtrp À/À mice ( Figure 7G ; cephalic skin). Transcript levels of some transcription factors that are known as regulators of Cdh5 and Cldn5 expression, such as Klf4 (parallel regulator 48 ) and Hif3a (repressor of Cdh5 49 ), were significantly changed in Adtrp À/À versus WT P 0 pups ( Table 2 ; cephalic skin).
We also observed defective PVC coverage, as illustrated by whole-mount immunofluorescence for desmin in cephalic skin and brain ( Figure 8A) , and for platelet-derived growth factor receptor beta in skin ( Figure 8B ).
Young Adtrp À/À Adult Mice Display Mild Vascular Dysfunction
Although the surviving pups grow into adulthood without displaying a severe vascular phenotype, adult Adtrp À/À mice (%3-months old, both males and females) present mild vascular dysfunction, such as bleeding spots ( Figure 9A ; red arrows) and fibrin deposition ( Figure 9B ), in the lung. Hematological and hemostasis/coagulation parameters measured in 2-month-old mouse plasma, such as blood cell counts including platelets (Table 3) Newborn Adtrp À/À Mice Display Vascular Defects, Degraded, and/or Decreased ECM, Interstitial Edema, and MC Accumulation ECM and basement membrane are important factors for vascular stability. 50, 51 Transmission electron microscopy of P 0 pups skin and tail revealed that, as opposed to WT ( Figure 10A and 10G) , Adtrp À/À mice showed degraded ECM, severe extravascular edema (red asterisks), distorted basement membrane (black asterisks), and deficient PVC coverage (black arrows; Figure 10B through 10E and 10H). Extravasated red blood cells, neutrophils, and MCs appear near the defective vessels ( Figure 10B , 10D, 10F, and 10H-right panel). Electron density and shape of ECs were heterogenous within the same vessel, indicating some extent of EC dysfunction (Figure 10B through 10E; labeled EC*). Similar heterogeneity was not observed in the PVC. Whole-mount immunofluorescence and western blot for laminin ( Figure 11A and 11B) and collagen-IV ( Figure 11C ) in the cephalic skin also illustrate basement membrane and ECM deficiencies.
One striking feature first observed on semithin sections of Adtrp À/À P 0 skin and confirmed by transmission electron microscopy was the accumulation of high numbers of MCs in skin ( Figure 10H ) and tail ( Figure 12A , yellow asterisks), many of which appear degranulated (black arrows) and coincide with edema (red asterisks) and extravasated red blood cells (blue arrow; Figure 12A ). Staining the diaphragm with Toluidine Blue confirmed significantly increased MC numbers in Adtrp À/À P 0 pups ( Figure 12B ). Whole-mount immunofluorescence for the MC marker, tryptase, revealed MC accumulation near defective vasculature ( Figure 12C ). qPCR on RNA from P 0 pups cephalic skin, lung, and heart showed significantly increased transcript levels for regulators of MC egression from the circulation, maturation, proliferation, and survival of MCs, 52 as well as for granule components involved in ECM degradation, vascular remodeling, and inflammation ( Table 2 ; cephalic skin).
ADTRP Negatively Regulates Canonical Wnt Signaling Both In Vitro and In Vivo
Because ADTRP deficiency in both zebrafish and mice produced vascular defects reminiscent of altered canonical Wnt signaling, 15, 16, 53 we decided to investigate the involvement of ADTRP in the Wnt/b-catenin pathway. Upon Wnt3a induction, ADTRP-siRNA knockdown in EA.hy926 EC (verified by western blot; Figure 13A ) produced significant increase of LEF1 and AXIN2 mRNA levels ( Figure 13B , gray bars) and increased active b-catenin protein expression ( Figure 13C ) and its nuclear translocation ( Figure 13D ). These results indicate an inverse correlation between ADTRP expression and canonical Wnt signaling. Conversely, ADTRP overexpression in HEK293T cells (verified by western blot; Figure 14A ) significantly decreased LEF1 and AXIN2 expression ( Figure 14B , gray bars) and TOPFlash reporter activity upon Wnt3a induction ( Figure 14C , gray bars), confirming that ADTRP inhibits Wnt/b-catenin signaling. Western blot confirmed the overall decrease of active b-catenin in ADTRP-expressing cells upon Wnt3a induction ( Figure 14D ), whereas immunofluorescence showed significantly less active b-catenin in the nuclei ( Figure 14E BAT-GAL z+ mice displayed strong b-GAL signal ( Figure 15A , Skin panels; pink arrows). In contrast with the (WT) BAT-GAL z+ brain, which showed high levels of b-GAL, but with little or no association with blood vessels, the Adtrp À/À BAT-GAL z+ brain displayed strong accumulation of b-GAL in defective vessels ( Figure 15A , brain panels; pink arrows). Skin from Adtrp À/À P 0 pups displayed both upregulated expression of Tcf4, the primary target of Wnt/ b-catenin ( Figure 15B ), and increased active b-catenin protein levels ( Figure 15C ). Lef1 expression was also significantly increased in fibroblasts isolated from Adtrp À/À skin explants versus WT ( Figure 15D ), indicating constitutively active Wnt/bcatenin signaling in Adtrp À/À dermal fibroblasts. Table 2 shows canonical Wnt signaling markers whose transcript levels were significantly changed in Adtrp À/À P 0 pups skin. When investigating downstream target genes of Wnt/ b-catenin signaling, which could produce the vascular defects observed in zebrafish morphants, we did not find changes in vascular markers like angptl4, egr1, vegfaa, efnb2a, dll4, and ephb4a. We did, however, find that mmp9 expression was 15-fold increased in 72-hpf adtrp morphants.
Whole-mount ISH showed strong signal for mmp9 in the dilated CVP ( Figure 16A ; blue arrow). Immunofluorescence on cross-sections of CVP revealed larger amounts of Mmp-9 around the dilated CVP in adtrp morphants than in controls, and human ADTRP mRNA reversed the Mmp-9 increase ( Figure 16B ). Gel zymography showed increased Mmp-9 activity in whole extracts of adtrp morphants ( Figure 16C ). Increased metallopeptidase activity was observed in the vicinity of dilated CVP by in situ zymography on adtrp morphant sections ( Figure 16D ).
To determine whether the increased MMP-9 activity contributed to the vascular defects in zebrafish, we used the MMP inhibitor GM6001, [24] [25] [26] [27] and observed that it reversed the increased MMP-9 activity ( Figure 16C ) and partially rescued the vascular defects in adtrp morphants ( Figure 16E ). In mice as well, Mmp9 expression was increased in skin (Table 2) , as well as in the lung and heart of P 0 pups (1.5-fold increase). Whole-mount immunofluorescence showed more MMP-9 staining in cells associated with defective vasculature in Adtrp À/À P 0 skin compared with WT ( Figure 16F ), both in CD31-positive ECs (lower panel inset) and GR-1-positive leukocytes, which also appear more numerous (middle panels). MCs in lung costained for MMP-9 (Figure 16F , Lung; yellow arrows). Conditioned media of dermal fibroblasts from P 0 skin contain significantly more MMP-9 protein and activity in Adtrp À/À than in WT ( Figure 16G ).
ADTRP Deficiency Enhances MMP-9 in a Wnt Signaling-Dependent Manner
Whole-mount immunofluorescence on lung from Adtrp À/À BAT-GAL z+ P 0 pups confirmed enhanced MMP-9 staining that partially colocalized with b-GAL-positive (active b-catenin reporter) cells ( Figure 17A ), some of which are MCs (data not shown). Mmp9 expression was significantly higher in dermal fibroblasts from Adtrp À/À P 0 pups versus WT, and Wnt3a dramatically increased the effect ( Figure 17B , gray bars), as well as in siADTRP EA.hy926 ECs compared with controls upon Wnt3a induction ( Figure 17C ). Treatment of zebrafish adtrp morphants with the Wnt inhibitor, IWR-1, 28,29 reversed the increased mmp9 expression (Figure 17D ), suggesting that this was partially dependent on Wnt signaling.
Inflammatory Response in ADTRP-Deficient Mice
RNA expression of several inflammatory markers was significantly increased in the cephalic skin of Adtrp À/À P 0 pups (Table 2) : KC/Cxcl1 (functional Interleukin-8 homolog); Itgam (CD11b); Itgax (CD11c); Lgals3 (galectin-3); Cd4; Vcam1; and Tnf. Expression of the major Wnt-target gene CXCL8 (interleukin-8) was over 2-fold ratio increased in zebrafish adtrp morphants and in siADTRP-EA.hy926 cells after Wnt3a induction.
Discussion
Our study is the first to address the physiological role of ADTRP in vascular development and function. For this purpose, we knocked down adtrp in zebrafish using MOs and developed a genetic mouse model of Adtrp global deletion. Use of MOs, as opposed to genetic knockouts in zebrafish, has been extensively debated, and each approach has its benefits and drawbacks. 31, 54, 55 We tried to overcome MO limitations by including the appropriate control and rescue experiments to allow us to distinguish between specific phenotypes and off-target effects, according to established guidelines. 54 We consider that zebrafish data add value to our findings given that they bring complementary information that supports the mouse data.
Adtrp À/À mice do not display hemostasis and/or coagulation defects, except for decreased plasma levels of TFPI antigen and activity, found equally in males and females.
Although not shown here, we found no difference of testosterone levels between WT and Adtrp À/À in plasma from %3-month-old mice. Contrary to our in vitro data 1 and a recent report, 30 Tfpi expression did not change either in Adtrp À/À mice (lung) or in the Adtrp-deficient zebrafish embryos, but TFPI-specific activity in mouse lung was significantly lower and probably caused the mild bleeding and fibrin deposition observed. These in vivo data support our previous findings 1 that ADTRP may control and preserve cellsurface distribution and anticoagulant potential of TFPI in ECs.
Whether any of these processes are dependent on androgen signaling remains to be determined. Zebrafish adtrp morphants display defective vascular patterning and incomplete development of ISVs, disorganized CVP network, and dilation. Similarly, newborn Adtrp À/À pups present vascular malformations in the low-pressure vasculature, including abnormal dilation, tortuosity and branching, increased permeability, ECM degradation, basement membrane defects, and extravascular edema. Severity of the phenotype correlates with mortality, producing %35% neo-/ perinatal lethality. These findings demonstrate a major role of ADTRP in vascular development and remodeling, as well as vessel integrity. Vessel leakiness in Adtrp À/À pups indicates increased permeability attributed to defective endothelial barrier integrity, which is a hallmark of inflammation, pathological angiogenesis, and edema. 56 Interendothelial junctions are the main structures maintaining tissue-fluid homeostasis. Major components of EC junctions are claudin-5 in tight junctions 57 and VEC and b-and c-catenins in adherens junctions. 56 VEC sequestering of b-catenin stabilizes the junctions and controls the interaction with mural cells. 56 If this sequestering is perturbed through either tyrosinephosphorylation of VEC and b-catenin by inflammatory mediators (such as tumor necrosis factor alpha [TNF-a]), or decreased VEC expression, then b-catenin will dissociate from VEC, enhance its nuclear translocation, 58 and transcriptionally repress Cldn5. 59 We suggest that the low mRNA and protein expression of VEC and claudin-5 in ADTRPdeficient cells triggered b-catenin nuclear translocation and disruption of EC barrier integrity, which led to leakiness, hemorrhage, and severe edema, in a scenario reminiscent of the chronic vascular leakage produced by low VEC expression in tumors. 57 These findings confirm that ADTRP is significantly involved in the formation of blood vessels and maintenance of the EC barrier. Some of the vascular defects in Adtrp-deficient zebrafish and mice could result from altered Wnt signaling, whereby stabilization of b-catenin correlates with defects of vessel length and branching, abnormal vessel dilation, and disorganized CVP. 15, 53, 60 Whereas baseline Wnt/b-catenin activity is necessary for vascular development during embryogenesis and tissue homeostasis and repair in the adult, 61, 62 aberrant Wnt signaling in pathological conditions like tumors provokes severely destabilized, twisted, and leaky blood vessels, 61, 63 features that resemble the defects produced by ADTRP deficiency. Our loss-of and gain-of ADTRP function assays in cell cultures stimulated with Wnt3a demonstrated that ADTRP negatively regulates the nuclear translocation of active b-catenin and its transcriptional TCF/LEF coactivator activity, which is the critical effector of canonical Wnt signaling. 58 We made similar discoveries in vivo, demonstrating significant temporally and spatially aberrant activation of the canonical Wnt pathway both in adtrp morphant zebrafish embryos and newborn Adtrp À/À BAT-GAL z+ mice. By manipulating Wnt-pathway members in vitro, we found that ADTRP most likely acts downstream of LRP6 phosphorylation but upstream of GSK-3b. The mechanism through which ADTRP inhibits Wnt signaling awaits elucidation, but it may involve binding to Axin-2 and/or signalosome formation, perhaps similarly to how ADTRP regulates TFPI distribution and activity in the EC plasma membrane. degrade ECM and destabilize the vascular wall directly or through pro-MMP activation, and increase perivascular inflammation, processes that are all associated with ADTRP deficiency. One caveat of our study is that we describe vascular defects generated by ADTRP deficiency in zebrafish embryos versus mouse neonates. Given that the vascular phenotype is already present in newborn mice and some of them are stillborn, it is likely that the defects appeared during embryonic development, probably at late gestation. A comprehensive study of embryonic stage-related vascular defects in Adtrp À/À mice is currently underway in our group, as are studies involving Adtrp conditional deletion in ECs using transgenic mice Tie2-Cre and Cdh5-Cre, and in MC using Mcpt5-Cre or Cpa3-Cre mice. Our studies unveil a novel and critical role of ADTRP in vivo in vascular development and vessel integrity and function. ADTRP deficiency leads to: vessel dilation, junction defects, hemorrhage, defective PVC coverage, ECM degradation, and edema, defects that could produce partial penetrant lethality in zebrafish embryos and newborn mice. We propose a major mechanism to explain the vascular dysfunction produced by ADTRP deficiency: the increased and/or temporally aberrant canonical Wnt signaling in ECs and MCs induces high levels of MMP-9 and large accumulation of MCs whose degranulation products maintain and amplify the vascular defects and inflammation. Whether ADTRP in vivo deficiency could impact diseases involving pathological disruption of the vascular wall, such as inflammation, deep vein thrombosis/venous thromboembolism, sepsis, or cancer, remains to be discovered. 
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